NebuMar

Organization name

Merckle GmbH

SRN

DE-MF-000018230

Manufacturer status

Active

8 warnings recorded — scroll inside the panel to see all entries.

• CW999

  Do not use NebuMar Nasal Congestion spray for more than 30 consecutive days.
• CW999

  Use only for the intended purpose.
• CW135

  EUDAMED did not publish a description for this code.
• CW277

  EUDAMED did not publish a description for this code.
• CW276

  In case concomitant use of nasal medicinal products is necessary, please contact your doctor or pharmacist.
• CW999

  If it is necessary to use medications administered through the nose at the same time, consult your doctor or pharmacist.
• CW011

  Report any serious incident that occur in relation to the device to the manufacturer and the competent authority.
• CW999

  Notify the manufacturer and the competent authority of any serious incident that occurs in relation to the product.

Primary placement in Spain; available across 1 country total.

Trade name

NebuMar

UDI-DI code

D-269931RA

Basic UDI-DI

B-269931RA

Reference / catalog number

269931

Issuing entity

EUDAMED

Risk category

Class IIa

Applicable legislation

MDD [Directive 93/42/EEC on medical devices]

Status

On the market

Quantity

1

Additional product description

—

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

No clinical sizes registered for this device.

• V9099VARIOUS DEVICES NOT INCLUDED IN OTHER CLASSES - OTHER

• Batch number
• Expiration date
• Manufacturing date
• Serial number
• Software identification